Ray Dalio acquired 433 Thousand Dexcom shares worth $59.7 Million. That's 0.33% of their equity portfolio (64th largest holding). The first Dexcom trade was made in Q3 2020. Since then Ray Dalio bought shares eight more times and sold shares on five occasions. The stake costed the investor $45.4 Million, netting the investor a gain of 32% so far.